CRISPR Therapeutics AG (CRSP): New Bullish Coverage

CRSP – JMP Securities initiates as a market outperform, $69PT. This price target represents a 34.01% upside over the stock’s previous closing price of $51.49.


Update: As of Dec. 13, 2018, this bullish analyst call has returned -35.06%.


Key Facts Surrounding This News Item


  • CRSP had a POWR Rating of A (Strong Buy) coming into today.
  • CRSP was 8.53% above its 10-Day Moving Average coming into today.
  • CRSP was 18.27% above its 20-Day Moving Average coming into today.
  • CRSP was 43.76% above its 50-Day Moving Average coming into today.
  • CRSP was 88.84% above its 100-Day Moving Average coming into today.
  • CRSP was 130.79% above its 200-Day Moving Average coming into today.
  • CRSP had returned +119.29% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About CRISPR Therapeutics AG (CRSP)


CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland. View our full CRSP ticker page with ratings, news, and more.

CRSP at a Glance

CRSP Current POWR Rating™
Overall POWR Rating™
CRSP Current Price $33.44 8.08%
More CRSP Ratings, Data, and News

CRSP Price Reaction

The day of this event (Mar. 8, 2018)
CRSP Closing Price$53.70 4.29%
CRSP Volume1,059,300
219.92% from avg
Leading up to this event
CRSP 1-mo return33.26%
After this event
CRSP 1-day return9.22%
CRSP 3-day return8.88%
CRSP 5-day return2.11%

CRSP Price Chart


The Top Stocks For 2019

More CRISPR Therapeutics AG (CRSP) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRSP News
Page generated in 0.9224 seconds.